BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2805Biotechnology
$29.51 +$0.14 (+0.48%)
Pre-market · Oct 6, 4:10 am ET · After hours $29.51 0.00%
Open$29.38
Prev close$29.37
Day range$29.24 – $29.91
Volume439.7K
Market cap$1.93B
P/E (TTM)2.9
Dividend yield–

Where the revenue comes from

Quarter 2025/FY

By region

  • United States of America$1.08B 97.2%
  • Europe$31.10M 2.8%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Cash flow

Line item 2026 Q2
(EUR)
2026 Q1
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q3
(EUR)
Other Non-Cash Items €47.63M -€73.66M -€100.84M -€393.21M €328.64M
Net Cash Flow from Continuing Investing Activities €101.42M €61.50M €288.81M €72.62M €56.74M
Net cash flow from investing €101.42M €61.50M €288.81M €72.62M €56.74M
-Change In Other Working Capital -€8.66M -€35.44M -€1.03B -€963.04M €17.64M
Change in Working Capital -€7.52M -€35.44M -€876.57M -€813.79M -€94.70M
Free Cash Flow -€34.12M -€82.87M -€271.32M -€49.07M -€65.46M
Net Income from Continuing Operations €2.11M €14.49M €320.88M €782.15M -€202.11M
Net cash flow from continuing operations -€34.09M -€82.75M -€257.46M -€47.46M -€62.61M
Operating Cash Flow -€34.09M -€82.75M -€257.46M -€47.46M -€62.61M
Net PPE Purchase and Sale €1.05M €1.19M -€13.24M -€1.22M -€2.77M
Net Intangibles Purchase and Sale €0.00 €0.00 -€155,000.00 €0.00 €0.00
Net Business Purchase and Sale -€731.75M €2.34M €19.43M €1.62M €8.08M
Effect of Exchange Rate Changes €5.76M €700,000.00 -€4.46M -€1.35M -€86,000.00
Beginning Cash Balance €66.81M €87.87M €64.24M €64.46M €71.67M
Net Change in Cash €63.39M -€21.76M €28.09M €24.76M -€7.13M
Ending Cash Balance €135.95M €66.81M €87.87M €87.87M €64.46M
Net Issuance Payments Of Debt -€1.07M -€510,000.00 -€3.27M -€405,000.00 -€1.26M
Net Cash Flow from Continuing Financing Activities -€3.94M -€510,000.00 -€3.27M -€405,000.00 -€1.26M
Financing Cash Flow -€3.94M -€510,000.00 -€3.27M -€405,000.00 -€1.26M
Net Investment Purchase and Sale €779.62M €57.96M €242.33M €67.15M €38.40M
-Change in Other Current Liabilities – – €33.81M – –
-Change in Inventory – – €28.85M – –
-Change in Receivables – – €86.59M – –
Deferred Tax – – -€18.14M – –
Depreciation & Depletion & Amortization – – €55.88M – –
Gain/Loss from Continuing Operations – – €17.68M – –
Net Other Investing Changes – – -€20.00M €0.00 €0.00

Discussion

No comments yet — be the first to weigh in on LKFT.

Leave a comment

Scroll to Top